145 related articles for article (PubMed ID: 18424102)
1. Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata.
Karioti A; Skaltsa H; Zhang X; Tonge PJ; Perozzo R; Kaiser M; Franzblau SG; Tasdemir D
Phytomedicine; 2008 Dec; 15(12):1125-9. PubMed ID: 18424102
[TBL] [Abstract][Full Text] [Related]
2. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
Tasdemir D; Topaloglu B; Perozzo R; Brun R; O'Neill R; Carballeira NM; Zhang X; Tonge PJ; Linden A; Rüedi P
Bioorg Med Chem; 2007 Nov; 15(21):6834-45. PubMed ID: 17765547
[TBL] [Abstract][Full Text] [Related]
3. Anthecularin: a novel sesquiterpene lactone from Anthemis auriculata with antiprotozoal activity.
Karioti A; Skaltsa H; Linden A; Perozzo R; Brun R; Tasdemir D
J Org Chem; 2007 Oct; 72(21):8103-6. PubMed ID: 17880246
[TBL] [Abstract][Full Text] [Related]
4. Linear sesquiterpene lactones from Anthemis auriculata and their antibacterial activity.
Theodori R; Karioti A; Rancić A; Skaltsa H
J Nat Prod; 2006 Apr; 69(4):662-4. PubMed ID: 16643047
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata.
Karioti A; Skaltsa H; Kaiser M; Tasdemir D
Phytomedicine; 2009 Aug; 16(8):783-7. PubMed ID: 19200703
[TBL] [Abstract][Full Text] [Related]
6. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
7. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
[TBL] [Abstract][Full Text] [Related]
8. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
10. The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.
Yogiara ; Mordukhova EA; Kim D; Kim WG; Hwang JK; Pan JG
Bioorg Med Chem Lett; 2020 Dec; 30(24):127651. PubMed ID: 33130290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants.
Tasdemir D; Brun R; Perozzo R; Dönmez AA
Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483
[TBL] [Abstract][Full Text] [Related]
12. Verrulactone C with an unprecedented dispiro skeleton, a new inhibitor of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.
Kim N; Sohn MJ; Koshino H; Kim EH; Kim WG
Bioorg Med Chem Lett; 2014 Jan; 24(1):83-6. PubMed ID: 24332629
[TBL] [Abstract][Full Text] [Related]
13. 4-Pyridone derivatives as new inhibitors of bacterial enoyl-ACP reductase FabI.
Kitagawa H; Kumura K; Takahata S; Iida M; Atsumi K
Bioorg Med Chem; 2007 Jan; 15(2):1106-16. PubMed ID: 17095231
[TBL] [Abstract][Full Text] [Related]
14. Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
Yao J; Zhang Q; Min J; He J; Yu Z
Bioorg Med Chem Lett; 2010 Jan; 20(1):56-9. PubMed ID: 19959361
[TBL] [Abstract][Full Text] [Related]
15. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
Zheng CJ; Sohn MJ; Chi SW; Kim WG
J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting activities of the secondary metabolites of Phlomis brunneogaleata against parasitic protozoa and plasmodial enoyl-ACP Reductase, a crucial enzyme in fatty acid biosynthesis.
Kirmizibekmez H; Calis I; Perozzo R; Brun R; Dönmez AA; Linden A; Rüedi P; Tasdemir D
Planta Med; 2004 Aug; 70(8):711-7. PubMed ID: 15326547
[TBL] [Abstract][Full Text] [Related]
17. Panosialins, inhibitors of enoyl-ACP reductase from Streptomyces sp. AN1761.
Kwon YJ; Sohn MJ; Oh T; Cho SN; Kim CJ; Kim WG
J Microbiol Biotechnol; 2013 Feb; 23(2):184-8. PubMed ID: 23412060
[TBL] [Abstract][Full Text] [Related]
18. Meleagrin, a new FabI inhibitor from Penicillium chryosogenum with at least one additional mode of action.
Zheng CJ; Sohn MJ; Lee S; Kim WG
PLoS One; 2013; 8(11):e78922. PubMed ID: 24312171
[TBL] [Abstract][Full Text] [Related]
19. Sesquiterpene lactones from Anthemis melanolepis and their antibacterial and cytotoxic activities. Prediction of their pharmacokinetic profile.
Saroglou V; Karioti A; Rancic A; Dimas K; Koukoulitsa C; Zervou M; Skaltsa H
J Nat Prod; 2010 Feb; 73(2):242-6. PubMed ID: 20112996
[TBL] [Abstract][Full Text] [Related]
20. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
